Academic Clinical Fellow in Medical Oncology at University College London Hospitals and The Francis Crick Institute (Swanton & Jamal-Hanjani Laboratories)
Dr Jonathan C. M. Wan is a medical oncology doctor and data scientist specialising in cancer liquid biopsy, particularly circulating tumour DNA (ctDNA). His research applies computational and AI-based methods to advance early cancer detection, disease monitoring, and predictive oncology.
He completed his PhD with Nitzan Rosenfeld at the Cancer Research UK Cambridge Institute, followed by postdoctoral training in the Diaz Lab at Memorial Sloan Kettering Cancer Center and the Swanton Lab at the Francis Crick Institute. He is a co-founder of Prima Mente (formerly cfdx).
Awards: Forbes 30 Under 30 (Healthcare & Science) and MIT Innovator Under 35 (Europe).
